riTUXimab
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
ri-tux-i-mab
![](.//images/locked-audio.png)
Trade Name(s)
- Riabni
- Rituxan
- Riximyo
- Ruxience
- Truxima
Ther. Class.
Pharm. Class.
monoclonal antibodies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "RiTUXimab." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51672/all/riTUXimab.
Vallerand AHA, Sanoski CAC, Quiring CC. RiTUXimab. Davis's Drug Guide. F.A. Davis Company; 2023. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51672/all/riTUXimab. Accessed September 7, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). RiTUXimab. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51672/all/riTUXimab
Vallerand AHA, Sanoski CAC, Quiring CC. RiTUXimab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2024 September 07]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51672/all/riTUXimab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - riTUXimab
ID - 51672
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51672/all/riTUXimab
PB - F.A. Davis Company
ET - 18
DB - Pediatrics Central
DP - Unbound Medicine
ER -